KOFA Healthcare Investments

KOFA concentrates on early-stage healthcare ventures, particularly medical devices, diagnostics, and digital health platforms. The firm targets companies where regulatory milestones and reimbursement pathways are already established, favoring capital-efficient models with clinical validation.

The firm's West Lafayette, Indiana location provides proximity to Purdue University and the broader Midwest academic-medical research corridor. This geographic position gives KOFA early visibility into university spinouts and clinically vetted founders before they reach larger coastal venture syndicates.

KOFA's investment structure and typical check size are not publicly disclosed. The firm participates through direct equity investments in healthcare companies, though its role as lead or follow-on investor varies by opportunity and syndicate composition.

KOFA invests across early venture and growth stages within healthcare, prioritizing companies that have progressed through initial regulatory processes. The firm looks for businesses where clinical data supports commercial adoption and the reimbursement framework is clear.

While the firm's primary geographic focus is North America, KOFA selectively evaluates opportunities in Western Europe where comparable regulatory and reimbursement structures exist.